BridgeMD
New treatment option for Obesity
Official title Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
ClinicalTrials.gov ID: NCT05804591
What this study is testing
What is Pregabalin 150mg?
Pregabalin 150mg is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for obesity.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Sleeve gastrectomy in patients with BMI \> 40 or \>35 with comorbidities
- Written informed consent
You likely can't join if
- Patient's refusal
- Known allergies to study medication
- Inability to comprehend or participate In pain scoring scale
- Inability to use intravenous patient controlled analgesia
- Changes of operation extent during procedure
- Revisional operations
See the full eligibility criteria
- Sleeve gastrectomy in patients with BMI \> 40 or \>35 with comorbidities
- Written informed consent
- Patient's refusal
- Known allergies to study medication
- Inability to comprehend or participate In pain scoring scale
- Inability to use intravenous patient controlled analgesia
- Changes of operation extent during procedure
- Revisional operations
- End stage organ failure
The study team makes the final eligibility decision.
Where it's taking place
- Warsaw, Warsaw, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Warsaw, Warsaw, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.